Incidence, predictors and outcome of upper gastrointestinal bleeding in patients with acute coronary syndromes

International Journal of Cardiology

Volumn 157, Issue 3, 2012, Pages 386-390

  Shalev, Aryeh ^a   Zahger, Doron ^a   Novack, Victor ^b   Etzion, Ohad ^a   Shimony, Avi ^a   Gilutz, Harel ^a   Cafri, Carlos ^a   Ilia, Reuben ^a   Fich, Alexander ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Soroka Clinical Research Center   (Israel)

Author keywords

Acute coronary syndromes; Antithrombotic therapy; Upper gastrointestinal bleeding

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PROTON PUMP INHIBITOR; STREPTOKINASE; THIENOPYRIDINE DERIVATIVE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; UPPER GASTROINTESTINAL BLEEDING;

ACUTE CORONARY SYNDROME; AGED; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYTIC AGENTS; GASTROINTESTINAL HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; UPPER GASTROINTESTINAL TRACT;

EID: 84858011178     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.12.081     Document Type: Article

References (35)

1. Anti-thrombotic Trialists Collaboration Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients BMJ 324 2002 71 86
2. S. Yusuf, F. Zhao, Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K. For the clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
3. J.W. Eikelboom, S.S. Anand, K. Malmberg, J.I. Weitz, J.S. Ginsberg, and S. Yusuf Unfractionated heparin and low-molecular-weight heparin in unstable angina and non-Q-wave myocardial infarction: a meta-analysis Lancet 355 2000 1936 1942
4. G.C. Wong, R.P. Giugliano, and E.M. Antman Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention JAMA 289 2003 331 342
5. E. Boersma, K.M. Akkerhuis, P. Theroux, R.M. Califf, E.J. Topol, and M.L. Simoons Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention Circulation 100 1999 2045 2048
6. S.R. Mehta, C.P. Cannon, and K.A. Fox Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials JAMA 293 2005 2908 2917
7. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
8. F.A. Spencer, M. Moscucci, and C.B. Granger GRACE Investigators. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 116 2007 2793 2801
9. J.J. Ferguson, R.M. Califf, and E.M. Antman SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy JAMA 292 2004 45 54
10. A.M. Lincoff, N.S. Kleiman, D.J. Kereiakes REPLACE-2 Investigators Long term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial JAMA 292 2004 696 703
11. G.W. Stone, B.T. McLaurin, D.A. Cox ACUITY Investigators Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 21 2006 Nov 23 2203 2216
12. G.W. Stone, B. Witzenbichler, G. Guagliumi HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 21 2008 May 22 2218 2230
13. C. Berry, J. Kelly, S.M. Cobbe, and H. Eteiba Comparison of femoral bleeding complications after coronary angiography versus percutaneous coronary intervention Am J Cardiol 94 2004 361 363
14. W.D. Piper, D.J. Malenka, and T.J. Ryan Jr. Northern New England Cardiovascular Disease Study Group. Predicting vascular complications in percutaneous coronary interventions Am Heart J 145 2003 1022 1029
15. L. Yatskar, F. Selzer, and F. Feit Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry Catheter Cardiovasc Interv 69 2007 961 966
16. E. Nikolsky, G.W. Stone, and A.J. Kirtane Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial J Am Coll Cardiol 54 14 2009 Sep 29 1293 1302
17. A.S. Levey, T. Greene, J. Kusek, and G. Beck A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract] J Am Soc Nephrol 11 2000 155A
18. K.P. Alexander, A.Y. Chen, and M.T. Roe et al; CRUSADE Investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes JAMA 294 2005 3108 3116
19. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 10 2007 Mar 8 1020 1029
20. F. Feit, M.D. Voeltz, and M.J. Attubato Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial Am J Cardiol 100 2007 1364 1369
21. G. Ndrepepa, P.B. Berger, and J. Mehilli Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697
22. A. Segev, B.H. Strauss, M. Tan, C. Constance, A. Langer Canadian Acute Coronary Syndromes Registries Investigators Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome Registries Am Heart J 105 2005 690 694
23. S.V. Rao, K. O'Grady, and K.S. Pieper Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
24. S.V. Manoukian, F. Feit, and R. Mehran Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial J Am Coll Cardiol 49 2007 1362 1368
25. M. Cohen Predictors of bleeding risk and long-term mortality in patients with acute coronary syndromes Curr Med Res Opin 21 2005 439 445
26. A.E. Abbas, B. Brodie, and S. Dixon Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction Am J Cardiol 96 2005 173 176
27. M.W.S. Chin, G. Yong, M. Bulsara, J. Rankin, and G.M. Forbes Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study Am J Gastroenterol 102 2007 2411 2416
28. M. Al-Mallah, R.N. Bazari, M. Jankowski, and M.P. Hudson Predictors and outcomes associated with gastrointestinal bleeding in patients with acute coronary syndromes J Thromb Thrombolysis 23 2007 51 55
29. M.S. Sabatine, D.A. Morrow, and R.P. Giugliano Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation 111 2005 2042 2049
30. S.V. Rao, J.G. Jollis, and R.A. Harrington Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562
31. T.Y. Wang, L. Xiao, and K.P. Alexander Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding Circulation 118 2008 2139 2145
32. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
33. J.H. Chesebro, G. Knatterud, and R. Roberts Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation 76 1987 142 154
34. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150
35. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2